Genome Medical Raises $14M in Funding
Summary
Genome Medical, a South San Francisco, CA-based telegenomics technology and services company democratizing access to genomic-based medicine, raised $14m in Series B extension funding. The company intends to use the funds to accelerated development of the Genome Care DeliveryTM technology platform for cancer, reproductive health and pharmacogenomics. Through a nationwide network of genetic specialists and efficient Genome Care Delivery technology platform, the company provides expert virtual genetic care for individuals and their families to improve health and well-being. It also helps health care providers and their patients navigate the field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. Genome Medical’s solutions are utilized by health systems, hospitals, payors, providers and employers to expand access to genetic health services.